- Home
- TD vs BSX Comparison
TD vs BSX Comparison
Compare TD & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TD | BSX |
|---|---|---|
| Founded | 1855 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.0B | 137.8B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | TD | BSX |
|---|---|---|
| Price | $94.58 | $96.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | $120.00 | ★ $125.88 |
| AVG Volume (30 Days) | 2.0M | ★ 9.5M |
| Earning Date | 12-04-2025 | 02-04-2026 |
| Dividend Yield | ★ 3.15% | N/A |
| EPS Growth | ★ 144.91 | 54.68 |
| EPS | ★ 8.25 | 1.87 |
| Revenue | ★ $45,149,067,348.00 | $19,349,000,000.00 |
| Revenue This Year | N/A | $21.05 |
| Revenue Next Year | $4.29 | $11.44 |
| P/E Ratio | ★ $11.19 | $51.37 |
| Revenue Growth | 18.83 | ★ 21.61 |
| 52 Week Low | $52.63 | $85.98 |
| 52 Week High | $94.83 | $109.50 |
Technical Indicators
Market Signals| Indicator | TD | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 81.85 | 48.33 |
| Support Level | $90.37 | $95.55 |
| Resistance Level | $94.83 | $96.48 |
| Average True Range (ATR) | 1.02 | 1.92 |
| MACD | 0.22 | 0.41 |
| Stochastic Oscillator | 96.23 | 82.55 |
Price Performance
Historical ComparisonAbout TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.